New Report: Angiotech Pharma Acquires Product Candidates and Technology Assets from Haemacure Corp

May 28, 2010 - PRLog -- Angiotech Pharmaceuticals, Inc. a specialty pharmaceutical and medical device company, announced the closing of its acquisition of certain product candidates and technology assets of Haemacure Corporation. Haemacure has been involved in proceedings under Canada's Bankruptcy and Insolvency Act and Chapter 11 of the US Bankruptcy Code. Through an asset sale transaction, Angiotech has acquired all of the relevant research and development activities, manufacturing operations, key personnel, and intellectual property rights necessary to pursue the commercialization of Haemacure's human biomaterial product candidates, namely, fibrin sealant and thrombin hemostat. According to GlobalData the rationale behind this transaction stems from the high opportunity and value that Angiotech could gain from entering the wound care market and the complementing product portfolios the transaction would bring along.

Scope

Details of the deal included

* History of previous deals or agreements between the two companies
* Rationale behind the deal
* Forecast market revenue for the global wound closure devices market
* Details of the acquired products in question

Reasons to buy

* Identify key M&A trends in the medical equipment market
* Track competitor product portfolios and acquisition history
* Assess future outlook of the company

For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/60972_angiotech_pharma_acquire...

Report Table of Contents:

1 Table of Contents 1
1.1 List of Tables 1
1.2 List of Figures 1
2 Angiotech Pharma Acquires Product Candidates and Technology Assets from Haemacure Corporation 1
2.1 What is this Report About? 1
2.2 Deal Background 1
2.3 Deal Rationale 2
2.4 The Acquired Products 3
3 Appendix 4
3.1 Research Methodology 4
3.2 Coverage 5
3.3 Secondary Research 5
3.4 Primary Research 5
3.5 Models 5
3.6 Forecasts 5
3.7 Expert Panels 6
3.8 GlobalData Consulting 6
3.9 Contact Us 6
3.10 Disclaimer 6

1.1 List of Tables
Table 1: Wound Closure Devices Market, Global, Revenue ($m), 2009 - 2016 3
Table 2: Hemaseel Thrombin Haemostatic Agent Product Details 4
Table 3: Hemaseel HMN fibrin sealant-Adhesion Prevention, Product Details 4
Table 4: Hemaseel HMN fibrin sealant-Hemostatis, Product Details 4

1.2 List of Figures
Figure 1: Wound Closure Market, Global, Revenue ($m), 2009 - 2016 2
Figure 2: GlobalData Methodology 4

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.  View more research from GlobalData at http://www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.